A novel magnetic FSM-16 supported ionic liquid/Pd complex as a high performance and recyclable catalyst for the synthesis of pyrano[3,2-c]chromenes

In this work, Fe3O4@FSM-16/IL-Pd was successfully designed and synthesized via a new procedure of palladium(ii) complex immobilization onto magnetic FSM-16 using an ionic liquid, as a novel heterogeneous nanocatalyst. Multiple techniques were employed to characterize this magnetic nanocatalyst such as Fourier transform infrared spectroscopy (FT-IR), Brunauer-Emmett-Teller (BET), X-ray diffraction (XRD), energy-dispersive X-ray spectroscopy (EDS), Field Emission Scanning Electron Microscopy (FE-SEM), thermogravimetric analysis (TGA), Transmission electron microscopy (TEM), and Vibrating Sample Magnetometry (VSM). After complete characterization of the catalyst, its catalytic activity was used for the synthesis of pyrano[3,2-c]chromene-3-carbonitriles via the reaction of 4-hydroxycoumarin, aldehyde, and malononitrile under solvent-free conditions. Also, it can be recovered and reused several times without a significant decrease in its catalytic activity or palladium leaching.

In vitro α-amylase and α-glucosidase inhibition study of dihydropyrimidinones synthesized via one-pot Biginelli reaction in the presence of a green catalyst

A green catalyst WELPSA-catalyzed three-component condensation (Biginelli) process involving an aldehyde, barbituric/thiobarbituric/1,3-dimethylbarbituric acid, and urea/thiourea/guanidine hydrochloride in a single pot in presence of a green solvent for the production of DHPM have been presented. The catalyst is reusable and this methodology is scalable. By using the in vitro experiments, the antidiabetic potentiality of synthesized compounds that inhibit α-amylase along with α-glucosidase efficiencies was assessed. All the synthesized compounds except for 4a and 4e, showed the most significant inhibition for α-amylase and α-glucosidase activities. Among the synthesized DHPM compounds, 4c and 4b exhibited significant inhibition profiles compared to the standard antidiabetic drug acarbose. Furthermore, synthesized substances' energy-minimized structures, 3D structures, and DFT calculations were performed using Gaussian 09 software, hybrid models, and MM2 force approaches. Strong hydrogen bonds with amino acid residues Arg-672, Arg-600, Trp-613, Asp-404, Asp-282, and Asp-616 indicate that an α-glucosidase-inhibitory peptide may have hypoglycemic efficacy confirmed by the molecular docking study of the synthesized DHPM.

Fe3O4@nano-almondshell/Si(CH2)3/2-(1-piperazinyl)ethylamine as an effective magnetite almond shell-based nanocatalyst for the synthesis of dihydropyrano[3,2-c]chromene and tetrahydrobenzo[b]pyran derivatives

The preparation and design of nano-catalysts based on magnetic biopolymers as green and biocompatible nano-catalysts have made many advances. This paper deals with the preparation of magnetite biopolymer-based Brønsted base nano-catalyst from a nano-almond (Prunus dulcis) shell. This magnetite biopolymer-based nano-catalyst was obtained through a simple process based on the core-shelling of nano-almond shell and Fe₃O₄ NPs and then the immobilization of 3-chloropropyltrimethoxysilane as linker and 2-aminoethylpiperazine as a basic section. Structural and morphological analysis of this magnetite biopolymer-based nano-catalyst were done using Fourier transform infrared spectroscopy, field emission scanning electron microscopy, X-ray diffraction, Thermogravimetric analysis, Vibrating sample magnetization, Energy-dispersive X-ray spectroscopy, Brunauer-Emmett-Teller, and Transmission electron microscopy techniques. The performance of the synthesized Fe₃O₄@nano-almondshell/Si(CH₂)₃/2-(1-piperazinyl)ethylamine as a novel magnetite biopolymer-based nano-catalyst for the synthesis of dihydropyrano[3,2-c]chromene and tetrahydrobenzo[b]pyran was investigated and showed excellent efficiency.